Kala Bio KALA
NASDAQ KALA
$0.82 -0.02 (-2.39%)
As of: Aug 21, 2026 · 3:58 PM EDT

Kala Bio (KALA) Net Equity Issued and Repurchased (2018 - 2026)

Kala Bio (KALA) posted Net Equity Issued and Repurchased of $4.1 million for Q1 2026, up 344.42% sequentially from $923000.0 in Q4 2024.

Kala Bio (KALA) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends

Kala Bio has reported Net Equity Issued and Repurchased for 7 years, with the latest figure at $4.1 million in Q1 2026.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (changed N/A YoY) and the FY2025 annual result came in at $1.8 million, down 46.97% from the prior year.
  • Net Equity Issued and Repurchased advanced to $4.1 million in Q1 2026 per KALA's latest filing, from $923000.0 in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $14.9 million in Q1 2023 and troughed at $570000.0 in Q4 2023.
  • A 3-year average of $4.8 million and a median of $3.6 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
  • The widest YoY moves for Net Equity Issued and Repurchased: up 61.93% in 2024, down 61.93% in 2024.
  • Over 3 years, Net Equity Issued and Repurchased stood at $570000.0 in 2023, then surged by 61.93% to $923000.0 in 2024, then soared by 344.42% to $4.1 million in 2026.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $4.1 million, $923000.0, and $4.9 million for Q1 2026, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Kala Bio 9.89 Mn 9.89 Mn - 4.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.10 Mn
Mar 31, 2026 4.10 Mn
Dec 31, 2024 923,000.00
Dec 31, 2024 923,000.00
Sep 30, 2024 4.94 Mn
Sep 30, 2024 4.94 Mn
Dec 31, 2023 570,000.00
Dec 31, 2023 570,000.00
Jun 30, 2023 3.07 Mn
Jun 30, 2023 3.07 Mn
Mar 31, 2023 14.89 Mn
Mar 31, 2023 14.89 Mn
Dec 31, 2021 169,000.00
Dec 31, 2021 169,000.00
Sep 30, 2021 333,000.00
Sep 30, 2021 333,000.00
Jun 30, 2021 6.02 Mn
Jun 30, 2021 6.02 Mn
Mar 31, 2021 34.71 Mn
Mar 31, 2021 34.71 Mn